Abstract. Background: Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy, but it is unclear how best to deliver PrEP to key populations. Drawing upon a cross-sectional survey of transgender women (TW) in Detroit, USA, and experience of a PrEP clinic that serves this population, this manuscript describes the following: (1) the risk profile of Detroit TW; (2) the proportion of TW with at least one PrEP indication; and (3) perceptions of and experiences with PrEP among TW in Detroit. Methods: Between August 2017 and March 2018, 126 TW completed an online PrEP survey. Survey responses were summarised using descriptive statistics and multivariable relative risk regression. Results: Among participants who reported a negative or unknown HIV status (76% of all participants), 56% reported risk behaviour(s) consistent with PrEP indication guidelines, 17% reported currently taking PrEP and another 4% reported discontinued PrEP use. Among participants who met an indication for PrEP but were not currently taking PrEP, 64% indicated that they were not interested in taking PrEP. Approximately 60% of participants who were not currently taking PrEP reported that they would be more likely to take PrEP if it were provided at a clinic that also provided hormone replacement therapy. Conclusions: Although a substantial proportion of TW in our survey were on PrEP, interest in PrEP among high-risk TW who were not taking it was low. Specialised clinical infrastructure that is responsive to the specific needs of TW may be needed to expand PrEP to this oftentimes marginalised and high-risk population.
Introduction
Transgender women (TW) worldwide are disproportionately affected by HIV.
1,2 They face biological, epidemiological, structural barriers and individual factors that contribute to their elevated HIV risk. [2] [3] [4] [5] HIV prevention programs designed for larger risk groups (e.g. cisgender men who have sex with men) may not adequately respond to the unique needs of transgender persons. 6 Stigma and discrimination corresponding to gender identity may pose barriers to accessing HIV prevention services, other health and social service programs, and economic opportunities. 4, 6, 7 Transgender persons are more likely to experience unemployment, unstable housing, addiction, sex work, incarceration and other challenges associated with economic insecurity that complicate engagement in HIVrelated programs. 7 HIV in the context of transgender health has been understudied, leaving several unanswered questions, such as: the effectiveness of HIV-related interventions in transgender communities; the potential for hormone replacement therapy (HRT) to interact with medications used to prevent and treat HIV; and potential for HRT and gender-affirming procedures to increase HIV acquisition risk. 4, 6, 8 The efficacy of pre-exposure prophylaxis (PrEP) among TW has only been evaluated in a single, post-hoc analysis of iPrEx clinical trial data, which concluded that PrEP was protective against HIV among transgender participants with evidence of high medication adherence, but not across all TW participants. 9 As PrEP's efficacy for TW has not been definitively proven, the Centers for Disease Control and Prevention (CDC) does not explicitly recommend PrEP for this risk group; instead, the guidelines state, in reference to transgender persons, that PrEP 'may be considered in all persons at risk of acquiring HIV sexually'. 10 In recent years, federal, state and local health departments in the US have increasingly recognised the need to focus greater attention on transgender populations. 6 Success addressing the HIV-related needs of this disproportionately affected community requires new, concerted efforts to provide prevention and care services, and to measure the risk and burden of disease and uptake of essential services. However, to date, local epidemiologic data collection and program evaluations that specifically focus on transgender persons have been extremely limited, and how local health departments can collect such data has not been well defined. Through a collaboration involving academically affiliated researchers, Detroit-based service providers, representatives of the Detroit TW community, and PrEP program managers and evaluators at the Michigan Department of Health and Human Services (MDHHS), we conducted a survey that assessed topics relating to PrEP among transgender women (TW) living in Wayne County, Michigan, USA. This survey was conducted as part of a National Institutes of Health (NIH)-funded evaluation of PrEP implementation programs in Wayne County, Michigan, USA.
11
Detroit is the largest city in Wayne County. According to the USA Census, Detroit is among the poorest major cities in the USA. 12 In 2014, Detroit declared bankruptcy, a process that required it to close its major public health building and contract out its sexually transmitted disease (STD) services. Based on 2014 National HIV Behavioural Surveillance data (NHBS), only 50% of HIV-infected MSM in Detroit knew their HIV status (the lowest level of any NHBS site) and only 59% had been HIV tested in the prior 12 months (the second lowest of any NHBS site). 13 In 2015-18, MDHHS received assistance from CDC to expand and enhance PrEP programs in Wayne County.
14 With this additional support, MDHHS has provided training to PrEP providers, developed a PrEP directory 11 and implemented a demand-generation campaign. While most of these activities have focussed on cisgender men who have sex with men (MSM), one Detroit PrEP provider, the Ruth Ellis Health and Wellness Center, 15 has developed a comprehensive approach to reaching the TW population.
Drawing on results from a cross-sectional survey of TW in Detroit and experiences of the Ruth Ellis Health and Wellness Center, we describe the following: (1) the proportion of Detroit TW who would meet at least one of CDC's indications for PrEP use among MSM; (2) perceptions of and experiences with PrEP among TW in Detroit; and (3) description of a clinical care model for delivering PrEP to TW at risk for HIV.
Methods
Between August 2017 and March 2018, we conducted a survey of TW in Detroit. The study enrolled a convenience sample of TW recruited by a peer advocate, community-based organisation (CBO) and social media posts and paid online advertising. The peer advocate is a TW who has extensive experience working with the Detroit TW community and advocating for transgender issues; she served as a consultant on the survey and recruited the majority of survey participants. The CBO serves the Wayne County lesbian, gay, bisexual and transgender (LGBT) community and recruited participants through in-person events and posts on their Facebook page. Participants recruited by the peer advocate (n = 89) or the CBO (n = 27) were given a US$20 Visa gift card for completing the 10-min survey. Several of the authors of this manuscript were simultaneously conducting an Internet Survey, primarily designed for cisgender-MSM, which used paid advertising on Grindr, Facebook and Instagram to recruit survey participants. People who clicked on the advertisements were directed to a page that included questions about gender identity. People who indicated that they were assigned male at birth and identified as transgender, non-binary or genderqueer were directed to the Trans Survey. This small subset of TW recruited through paid advertising (n = 10) did not receive an incentive.
To be eligible for the survey, participants had to: (1) reside in the Detroit metropolitan area; (2) be assigned male at birth; and (3) identify as transgender or nonbinary/genderqueer. Participants completed the survey in English on a tablet provided by the peer advocate or CBO or on their personal device. The survey was hosted by REDCap, a secure web application. 16 This survey was conducted as part of a larger evaluation of PrEP expansion activities in Wayne County, MI, USA. The Wayne State University institutional review board (IRB) concluded this assessment was non-research and was therefore not required to undergo an IRB review.
Pre-exposure prophylaxis was defined in the survey as 'a medication that can be taken by HIV-negative people on an ongoing basis to help prevent getting HIV. It is currently available under the brand name, Truvada, a picture of a Truvada pill accompanied the definition. Subsequent survey questions about PrEP were presented to respondents who did not report a HIV-positive status; skip patterns were deployed based on participants' reported experience with PrEP. We used descriptive statistics to characterise the survey sample and responses to PrEP-related questions, and adjusted prevalence ratios to evaluate factors associated with PrEP awareness and uptake. Age, Black/African American race, homelessness in the last 12 months, having health insurance, hormone replacement therapy, reporting one or more indications for PrEP and mode of recruitment were included in the models as independent variables. The survey defined 'sex' as 'penis-in-butt' or 'penis-in-vagina' sex. Indications for PrEP were adapted from the CDC clinical guidelines developed for MSM and included report of the following in the past 12 months: a bacterial STD diagnosis; exchange sex; 10 sex partners; condomless sex with a HIV-positive partner; or condomless sex with a partner assigned male at birth (hereafter referred to as PrEP indications). We used c 2 tests to evaluate bivariate associations. Adjusted prevalence ratios were estimated using a multivariable Poisson regression model with robust error variance.
Results

Sample description
A total of 126 TW completed the survey, of whom 71% were recruited by a peer advocate, 21% by a CBO and 8% through social media (Table 1) . Over half (54%) of participants were aged under 30 years and 64% were Black/African American. Three-quarters of participants identified as 'a woman' or 'transgender'; another 8% identified as non-binary/genderqueer and 15% reported multiple gender identities. Seventy percent were currently taking HRT. Although many participants (40%) had experienced homelessness in the prior year, most had health insurance (79%) and a regular medical provider (73%). Dissatisfaction with healthcare providers was common: 54% of participants indicated that they had felt disrespected at health facilities, 59% had postponed getting services because clinics were not trans-inclusive, 36% indicated that it was difficult to obtain HIV/STD services that are sensitive to the needs of trans patients and 81% indicated that they would prefer to receive medical care at a clinic that specialises in transgender care. Twenty-four percent self-reported being HIV positive and 13% reported not knowing their HIV status.
Responding to questions about their sexual risk behaviours in the prior year, 25% of participants reported having condomless sex with a partner of an opposite or unknown HIV status; 24% reported penetrative sex with 10 partners; 43% reported exchanging sex for money, drugs or housing; and 16% reported being diagnosed with syphilis, gonorrhoea or Table 1 chlamydia. Nearly half of participants (48%) reported drug use; the most commonly reported types of drug used 'to get high' were cocaine (used by 38% of participants) and prescription painkillers (used by 19% of participants). HIVpositive respondents were significantly more likely to have experienced homelessness, used drugs, exchanged sex and had 10 penetrative sex partners in the 12 months preceding the survey (P < 0.05). Over half (56%) of participants who did not report a positive HIV status met at least one of the indications for PrEP according to our adaptation of the CDC PrEP guidelines.
Knowledge, opinions and experiences with PrEP
Among participants who reported a negative or unknown HIV status (n = 96), 17% reported currently taking PrEP and another 4% reported that they had previously used PrEP but had discontinued it. Among participants who met an indication for PrEP (n = 54), 19% reported currently using PrEP and 5% reported that they had discontinued PrEP use ( Table 2) . In multivariable analyses, PrEP use was not significantly associated with age, being Black/African American, homelessness, meeting CDC indication for PrEP, drug use or HRT (Table 3) . Among participants who met an indication for PrEP but were not currently taking PrEP (n = 44), 64% indicated that they had previously heard of PrEP, 64% indicated that they were not interested in taking PrEP and 32% indicated that they had spoken to a healthcare provider about PrEP in the past year (Table 2) . Among non-PrEP users who did not meet an indication for PrEP, the corresponding percentages were lower. Approximately 60% of participants who were not currently taking PrEP reported that they would be more likely to take PrEP if it were provided at a clinic that also provided HRT. In multivariable analyses, the proportion reporting that they had heard of PrEP was significantly greater among participants currently taking HRT (aPR = 1.64, 95% CI = 1.01-2.54). In multivariable analyses, the proportion expressing interest in PrEP was significantly lower among participants with an indication for PrEP than participants without an indication for PrEP (aPR = 0.54, 95% CI = 0.33-0.91). Otherwise, no other factor was significantly associated with PrEP awareness or interest level. Among participants expressing interest in taking PrEP who were not already taking PrEP and not known to be HIV positive, 68% indicated a preference to receive PrEP from their regular medical provider.
Among current PrEP users (n = 16), most had initiated PrEP in the prior 12 months. Only one PrEP user reported out-ofpocket costs associated with PrEP. Three-quarters of PrEP users indicated that they received HRT from their PrEP provider. Sixty percent of current PrEP users reported taking PrEP 30 of the past 30 days. Based on an adaptation of Centers for Disease Control and Prevention pre-exposure prophylaxis (PrEP) guidelines. Restricted to participants who did not report a positive HIV status; defined as reporting one or more of the following in the past 12 months: bacterial sexually transmitted disease diagnosis, exchange sex, 10 sex partners, condomless sex with a HIV-positive partner or condomless sex with a partner assigned male at birth.
PrEP service delivery model for the transgender community: example from Detroit, Michigan, USA
Many of the PrEP users who completed the survey reported receiving PrEP-related care from the Ruth Ellis Health and Wellness Center. Ruth Ellis is a non-profit organisation that serves the lesbian, gay, bisexual and transgender (LGBT) community in Detroit. Key aspects of the centre's approach to TW health are described in Table 4 , and include: providing PrEP in conjunction with HRT; integrating clinical and social services; enabling flexible scheduling and walk-in appointments; disbursing prescriptions on-site; and creating a clinical environment that is trusted by the community. Ruth Ellis's clinical and programmatic experience in Detroit, in conjunction with findings from our survey, suggest that more focussed clinical infrastructure might be needed to deliver PrEP to TW.
Discussion
Approximately half of the TW included in the survey sample met at least one of the indications for PrEP, among whom nearly 20% were currently taking PrEP. Although awareness of PrEP was relatively high, interest in PrEP among non-users with indications to initiate PrEP was low. Most PrEP users were receiving PrEP in conjunction with other gender-affirming clinical services, particularly HRT, and participants expressed an interest in receiving PrEP and HRT from the same clinic. Pre-exposure prophylaxis awareness and use was higher in this sample than that reported previously in the peer-reviewed literature; 17,18 much of which described data collected before 2015. These estimates were similar to more recent data collected among transgender people attending the Seattle Trans* Pride Festival in June 2017 19 and MSM who completed a 2017 online survey in Michigan (unpublished A ) and MSM who completed surveys at 2017 Detroit Pride events (unpublished A ). Although our sample was small and of uncertain representativeness, the fact that use was substantially higher than that found in data collected even a few years ago suggests that PrEP use among TW could be changing very rapidly and highlights the need for ongoing efforts to monitor PrEP uptake in diverse populations.
Perhaps out most concerning findings was that almost twothirds of non-PrEP-using TW who had indications for initiating PrEP were uninterested in doing so. Indeed, fewer than 10% of non-users with indications wanted to initiate PrEP, a proportion that was significantly lower than what we observed in TW without indications for PrEP. While it is possible that the criteria we used to define PrEP indications was not an accurate measure of risk, our findings suggest that demand for PrEP among TW in Detroit is too low. Among MSM who completed the Michigan Online Survey and Detroit Pride Surveys (unpublished A ), the most common barriers to using PrEP were perceptions of not being at risk for HIV, financial barriers and insufficient information about PrEP and where to get it.
A Additional evaluation is needed to determine the extent to which Detroit TW face same or different barriers and to develop demand-creation strategies.
Our findings suggest that one way to increase TW's interest in and use of PrEP is to integrate the intervention into the provision of more comprehensive gender-affirming services. Sixty-one percent of non-PrEP users indicated they would be more likely to take PrEP if they could get it at a clinic that also provides HRT, and 71% of PrEP users report getting PrEP from the same clinic that they get HRT. Receipt of HRT was the only variable significantly associated with PrEP awareness in multivariable analyses. Offering PrEP alongside HRT management may represent a powerful strategy to promote PrEP initiation and retention among TW, which has been noted by others. 19, 20 Although some authorities have raised concerns about interactions between tenofovir/emtricitibine and HRT -a topic that merits additional research -at present, the preponderant view is that these concerns should not discourage PrEP use in transgender persons on HRT. A The authors are planning to publish the results from these surveys in a separate manuscript.
More broadly, efforts to reduce stigma in healthcare settings and prevention programs is critically needed in order to reach disenfranchised TW and to provide culturally appropriate services that are responsive to their unique needs and health priorities. In our survey, over half of participants expressed that they had felt disrespected at health facilities and had postponed getting services because clinics were not trans-inclusive; one-third indicated difficulty accessing HIV/ STD services that met their needs. Healthcare workers at all levels should receive cultural competency trainings and guidance on how to best serve transgender patients. Additionally, clinics that specialise in transgender health care, like the Ruth Ellis Health and Wellness Center, are also needed. Novel approaches to delivering services to TW, such as availability of walk-in appointments; onsite disbursement of prescriptions; integration of physical, behavioural and psychosocial health services; co-location with social services; and an environment trusted by the community as a 'safe space', may not be possible to implement in traditional healthcare settings. Indeed, 81% of our survey participants indicated that they would prefer to receive care at a clinic that specialised in transgender care. In summary, our healthcare system should strive to: (1) prepare all clinics to be capable of providing care to TW patients in a culturally competent manner; and to (2) establish a clinic(s) that specialises in transgender care, offering service delivery models that are responsive to this population's unique needs.
Half of the PrEP users in our survey reported taking PrEP less than daily, which may reflect structural challenges (e.g. discrimination, poverty, unstable housing) that disproportionately affects this population. Given that the efficacy of PrEP relies upon high adherence, PrEP providers should consider coupling prescriptions with interventions to promote PrEP adherence, such as adherence counselling, technology-based interventions (e.g. texting, mobile apps) and peer-support. 10, 22, 23 Nonetheless, these types of adherence promotion activities may not guarantee perfect adherence; many survey participants reporting suboptimal adherence were receiving PrEP from a clinic that provides comprehensive services (described in Table 4 ). This finding underscores the Trusted as a safe and supportive space With nearly 20 years of experience serving the Detroit LGBT community, Ruth Ellis has established itself as a trustworthy service provider. It is located adjacent to a public park that serves as a central gathering place for the Detroit LGBTQ community and one of the primary hubs for commercial sex work. Clinical and non-clinical staff undergo training and have cultivated expertise regarding the unique challenges and circumstances facing the population it serves. In addition to the services described above, Ruth Ellis also serves LGBT youth in the foster home system and family preservation program. Its reputation as a 'safe space' is cemented through word-of-mouth in the transgender community.
need for long-acting PrEP or regimens that do not require daily dosing, especially among vulnerable populations. There were several limitations to the survey conducted among TW in Detroit. First, it relied upon convenience sampling, and the representativeness of this sample of all TW in Detroit is unknown. Thus, it is possible that our measures of PrEP awareness and uptake were either too high or too low. Second, this survey did not collect information about reasons why TW were disinterested in PrEP, key information for demand-creation activities. Finally, although this survey reached a high-risk key population, the relatively small number of respondents caused the multivariate analyses to be underpowered. As such, we were largely unable to identify factors significantly associated with PrEP awareness, interest and uptake.
Transgender women in Detroit-and likely in other innercity settings-are a key population for HIV prevention efforts. A large proportion of TW who completed our survey were already HIV-infected; many reported drug use, exchange sex, condomless sex and a recent STD diagnosis; and approximately half met at least one of indicator for PrEP use adapted from CDC PrEP guidelines. Although a significant number of TW in our survey were on PrEP, interest in PrEP among high-risk TW who were not taking it was low. Our findings highlight the need to better understand why so many TW seem disinterested in PrEP, while also suggesting that PrEP can be successfully disseminated to a largely low-income, African American population of TW when the intervention is embedded into a wider menu of clinical services. These findings should prompt clinicians, healthcare organisations and public health authorities to promote the development of specialised clinical infrastructure to serve the specific needs of TW.
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